73 related articles for article (PubMed ID: 21509942)
21. An in vitro characterization study of new near infrared dyes for molecular imaging.
Pauli J; Vag T; Haag R; Spieles M; Wenzel M; Kaiser WA; Resch-Genger U; Hilger I
Eur J Med Chem; 2009 Sep; 44(9):3496-503. PubMed ID: 19269067
[TBL] [Abstract][Full Text] [Related]
22. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors.
Xiong L; Chen Z; Tian Q; Cao T; Xu C; Li F
Anal Chem; 2009 Nov; 81(21):8687-94. PubMed ID: 19817386
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of a cell-permeable near-infrared fluorescent deoxyglucose analogue for cancer cell imaging.
Vendrell M; Samanta A; Yun SW; Chang YT
Org Biomol Chem; 2011 Jul; 9(13):4760-2. PubMed ID: 21614387
[TBL] [Abstract][Full Text] [Related]
24. In vivo detection of macrophage recruitment in hind-limb ischemia using a targeted near-infrared fluorophore.
Yoo JS; Das RK; Jow ZY; Chang YT
PLoS One; 2014; 9(7):e103721. PubMed ID: 25072508
[TBL] [Abstract][Full Text] [Related]
25. PAMAM structure-based multifunctional fluorescent conjugates for improved fluorescent labelling of biomacromolecules.
Wängler C; Moldenhauer G; Saffrich R; Knapp EM; Beijer B; Schnölzer M; Wängler B; Eisenhut M; Haberkorn U; Mier W
Chemistry; 2008; 14(27):8116-30. PubMed ID: 18752247
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
Fan Z; Baselga J; Masui H; Mendelsohn J
Cancer Res; 1993 Oct; 53(19):4637-42. PubMed ID: 8402640
[TBL] [Abstract][Full Text] [Related]
27. Imaging membrane intercalating near infrared dyes to track multiple cell populations.
Roy EJ; Sivaguru M; Fried G; Gray BD; Kranz DM
J Immunol Methods; 2009 Aug; 348(1-2):18-29. PubMed ID: 19559026
[TBL] [Abstract][Full Text] [Related]
28. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
29. Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models.
Kovar JL; Volcheck W; Sevick-Muraca E; Simpson MA; Olive DM
Anal Biochem; 2009 Jan; 384(2):254-62. PubMed ID: 18938129
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
31. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent.
Asano R; Sone Y; Makabe K; Tsumoto K; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
Clin Cancer Res; 2006 Jul; 12(13):4036-42. PubMed ID: 16818703
[TBL] [Abstract][Full Text] [Related]
32. Validation of nanobody and antibody based in vivo tumor xenograft NIRF-imaging experiments in mice using ex vivo flow cytometry and microscopy.
Bannas P; Lenz A; Kunick V; Fumey W; Rissiek B; Schmid J; Haag F; Leingärtner A; Trepel M; Adam G; Koch-Nolte F
J Vis Exp; 2015 Apr; (98):e52462. PubMed ID: 25867711
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of a stable bacteriochlorophyll-analog and its incorporation into high-density lipoprotein nanoparticles for tumor imaging.
Cao W; Ng KK; Corbin I; Zhang Z; Ding L; Chen J; Zheng G
Bioconjug Chem; 2009 Nov; 20(11):2023-31. PubMed ID: 19839633
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent nanocrystals for use in early cervical cancer detection.
Nida DL; Rahman MS; Carlson KD; Richards-Kortum R; Follen M
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S89-94. PubMed ID: 16139342
[TBL] [Abstract][Full Text] [Related]
35. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
[TBL] [Abstract][Full Text] [Related]
36. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
37. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
Goldstein NI; Prewett M; Zuklys K; Rockwell P; Mendelsohn J
Clin Cancer Res; 1995 Nov; 1(11):1311-8. PubMed ID: 9815926
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of self-assembled CdHgTe/gelatin nanospheres as stable near infrared fluorescent probes in vivo.
Wang Y; Ye C; Wu L; Hu Y
J Pharm Biomed Anal; 2010 Nov; 53(3):235-42. PubMed ID: 20233648
[TBL] [Abstract][Full Text] [Related]
39. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
Teramoto T; Onda M; Tokunaga A; Asano G
Cancer; 1996 Apr; 77(8 Suppl):1639-45. PubMed ID: 8608556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
